231 related articles for article (PubMed ID: 15539550)
21. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
Meyer JH; Wilson AA; Sagrati S; Hussey D; Carella A; Potter WZ; Ginovart N; Spencer EP; Cheok A; Houle S
Am J Psychiatry; 2004 May; 161(5):826-35. PubMed ID: 15121647
[TBL] [Abstract][Full Text] [Related]
22. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.
Javors MA; Seneviratne C; Roache JD; Ait-Daoud N; Bergeson SE; Walss-Bass MC; Akhtar FZ; Johnson BA
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):7-13. PubMed ID: 15610939
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism of the serotonin transporter: implications for the use of selective serotonin reuptake inhibitors.
Lotrich FE; Pollock BG; Ferrell RE
Am J Pharmacogenomics; 2001; 1(3):153-64. PubMed ID: 12083964
[TBL] [Abstract][Full Text] [Related]
24. Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice.
Budygin EA; John CE; Mateo Y; Jones SR
J Neurosci; 2002 May; 22(10):RC222. PubMed ID: 12006604
[TBL] [Abstract][Full Text] [Related]
25. Serotonergic effects of smoking are independent from the human serotonin transporter gene promoter polymorphism: evidence from auditory cortical stimulus processing.
Gallinat J; Kunz D; Lang UE; Kalus P; Juckel G; Eggers J; Mahlberg R; Staedtgen M; Wernicke C; Rommelspacher H; Smolka MN
Pharmacopsychiatry; 2005 Jul; 38(4):158-60. PubMed ID: 16025417
[TBL] [Abstract][Full Text] [Related]
26. Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice.
Esaki T; Cook M; Shimoji K; Murphy DL; Sokoloff L; Holmes A
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5582-7. PubMed ID: 15809439
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of immunolabeling for serotonin and for glutamate transporters after administration of imipramine and citalopram.
Williams SM; Bryan-Lluka LJ; Pow DV
Brain Res; 2005 May; 1042(2):224-32. PubMed ID: 15854594
[TBL] [Abstract][Full Text] [Related]
28. Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background.
Holmes A; Lit Q; Murphy DL; Gold E; Crawley JN
Genes Brain Behav; 2003 Dec; 2(6):365-80. PubMed ID: 14653308
[TBL] [Abstract][Full Text] [Related]
29. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice.
Bengel D; Murphy DL; Andrews AM; Wichems CH; Feltner D; Heils A; Mössner R; Westphal H; Lesch KP
Mol Pharmacol; 1998 Apr; 53(4):649-55. PubMed ID: 9547354
[TBL] [Abstract][Full Text] [Related]
30. Serotonin transporter polymorphism and potential response to SSRIs in bulimia nervosa.
Monteleone P; Santonastaso P; Tortorella A; Favaro A; Fabrazzo M; Castaldo E; Caregaro L; Fuschino A; Maj M
Mol Psychiatry; 2005 Aug; 10(8):716-8. PubMed ID: 15940301
[No Abstract] [Full Text] [Related]
31. Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice.
Montañez S; Owens WA; Gould GG; Murphy DL; Daws LC
J Neurochem; 2003 Jul; 86(1):210-9. PubMed ID: 12807440
[TBL] [Abstract][Full Text] [Related]
32. siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain.
Thakker DR; Natt F; Hüsken D; van der Putten H; Maier R; Hoyer D; Cryan JF
Mol Psychiatry; 2005 Aug; 10(8):782-9, 714. PubMed ID: 15940298
[TBL] [Abstract][Full Text] [Related]
33. A cocaine insensitive chimeric insect serotonin transporter reveals domains critical for cocaine interaction.
Sandhu SK; Ross LS; Gill SS
Eur J Biochem; 2002 Aug; 269(16):3934-44. PubMed ID: 12180970
[TBL] [Abstract][Full Text] [Related]
34. Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse.
Weizman A; Weizman R
Pharmacogenomics; 2000 Aug; 1(3):335-41. PubMed ID: 11256582
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter.
Holmes A; Yang RJ; Murphy DL; Crawley JN
Neuropsychopharmacology; 2002 Dec; 27(6):914-23. PubMed ID: 12464448
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT).
Bryan-Lluka LJ; Papacostas MH; Paczkowski FA; Wanstall JC
Br J Pharmacol; 2004 Sep; 143(1):63-70. PubMed ID: 15302679
[TBL] [Abstract][Full Text] [Related]
37. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study.
Gobbi G; Murphy DL; Lesch K; Blier P
J Pharmacol Exp Ther; 2001 Mar; 296(3):987-95. PubMed ID: 11181933
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of 2-(4-fluorophenoxy)-2-phenyl-ethyl piperazines as serotonin-selective reuptake inhibitors with a potentially improved adverse reaction profile.
Dorsey JM; Miranda MG; Cozzi NV; Pinney KG
Bioorg Med Chem; 2004 Mar; 12(6):1483-91. PubMed ID: 15018922
[TBL] [Abstract][Full Text] [Related]
39. S-[18F]fluoromethyl-(+)-McN5652, a PET tracer for the serotonin transporter: evaluation in rats.
Marjamäki P; Zessin J; Eskola O; Grönroos T; Haaparanta M; Bergman J; Lehikoinen P; Forsback S; Brust P; Steinbach J; Solin O
Synapse; 2003 Jan; 47(1):45-53. PubMed ID: 12422372
[TBL] [Abstract][Full Text] [Related]
40. Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment.
Putzhammer A; Schoeler A; Rohrmeier T; Sand P; Hajak G; Eichhammer P
Psychopharmacology (Berl); 2005 Mar; 178(2-3):303-8. PubMed ID: 15322730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
